Senior correspondent Jay Hancock, Kaiser Health News, discusses drug pricing and how he expects pharmaceutical companies to tackle these issues in a Facebook Live discussion. Drug pricing is something that will ultimately impact the entire industry, so it’s important to keep up-to-date on the latest discussions happening at the state and federal level. In 2018, Jay predicts we’ll see more state level initiatives to pass drug transparency bills as well as more states leveraging their Medicaid buying power to gain influence over industry.

Visit Article Now